Different dosing regimens for propofol induction in obese patients

Area of Science:

• Anesthesiology
• Pharmacology
• Obesity Medicine

Background:

• Obese patients require careful anesthetic management due to altered pharmacokinetics and pharmacodynamics.
• Propofol is a common induction agent, but optimal dosing in obesity remains debated.
• Bariatric surgery necessitates precise anesthetic techniques to ensure patient safety.

Purpose of the Study:

• To compare the efficacy of propofol induction using total body weight (TBW) versus corrected body weight (CBW60) in obese patients undergoing bariatric surgery.
• To evaluate the impact of different propofol dosing strategies on anesthesia depth and hemodynamic stability.

Main Methods:

• A randomized study involving 38 obese patients (BMI ≥ 30 kg/m²).
• Patients received a single bolus of propofol (2 mg/kg) based on either TBW or CBW60.
• Bispectral index (BIS) values and hemodynamic parameters were monitored and compared between groups.

Main Results:

• The CBW60 group received a significantly lower total propofol dose (189.5 ± 36.3 mg) compared to the TBW group (217.3 ± 39.1 mg; p = 0.03).
• BIS values and post-intubation blood pressure showed no significant differences between groups.
• Hypotension occurred in 83% of patients, with no significant difference in its incidence between the TBW and CBW60 groups.

Conclusions:

• Dosing propofol based on CBW60 in obese patients undergoing bariatric surgery leads to reduced drug consumption.
• CBW60 dosing provides comparable anesthesia depth and hemodynamic effects to TBW dosing.
• This suggests CBW60 may be a viable alternative for propofol induction in this patient population.